biosensor preferably bears two or more different species of biological binding partner. The Sensor is fabricated by providing a plurality of groups of optical fibers. Each group is treated as a batch to attach a different Species of biological binding partner to the Sensor ends of the fibers comprising that bundle. Each fiber, or group of fibers within a bundle, may be uniquely identified So that the fibers, or group of fibers, when later combined in an array of different fibers, can be discretely addressed. Fibers or groups of fibers are then Selected and discretely separated from different bundles. The discretely separated fibers are then combined at their Sensor ends to produce a high density Sensor array of fibers capable of assaying Simultaneously the binding of components of a test Sample to the various binding partners on the different fibers of the sensor array. The transmission ends of the optical fibers are then discretely addressed to detectors-Such as a multiplicity of optical Sensors. An optical Signal, produced by binding of the binding partner to its Substrate to form a binding complex, is conducted through the optical fiber or group of fibers to a detector for each discrete test. By examining the addressed transmission ends of fibers, or groups of fibers, the addressed transmis Nature, 214: 986 (1967) , Abdel-Latif et al., Anal. Lett., 21: 943 (111988); Giaever, J. Immunol., 110: 1424 (1973 ; Sugao et al. Anal. Chem, 65:363 (1993) , Rogers et al. Anal. Biochem., 182: 353 (1989) . No. 4, 582, 809 and 4, 909, 990 to Block et al.) . In order to maximize Sensitivity and Selectivity Such biosensors typi cally utilize a single species of biological binding molecule affixed to the face of the sensor.
0006 Such "single-species' biosensors are limited in that they have no inherent means to correct or calibrate for non-specific binding. Thus, they must be calibrated against an external Standard. In addition, they are limited to the detection of a Single analyte. 0007 Biosensors comprising two or more species of biological binding partners overcome these limitations. A "multi-species' biosensor in principle permits simultaneous detection of as many different types of analytes as there are Species of biological binding partner incorporated into the Sep. 26, 2002 Sensor. In addition, comparison of the amounts of a Single analyte binding to multiple Species of binding partner pro vides a measure of non-specific binding and thus acts as an intrinsic control for measurement variability introduced by non-specific binding. 0008. In addition, the inclusion of fibers bearing biologi cal binding partnerS Specific for various analytes known to create a background Signal in a particular assay provides a means for Simultaneously measuring and Substracting out the background Signal. The provision of a multiplicity of fibers bearing different Species of binding partner allows the detection of a multiplicity of moieties contributing to a background, or other, Signal and the dissecting out of the contribution of each moiety to that Signal. 0009. To be most useful, a multi-species biosensor requires that the Sensor provide a separate signal character izing binding of analytes to each of the various species of binding partner comprising the probe. Thus each Species of binding partner must be individually "addressed".
0010. In addition, a "sensor face" (the surface bearing the biological binding partners) that has a relatively Small Surface area will facilitate measurement of Small Sample Volumes as leSS Sample material will be required to fully immerse the Sensor face. A Small Surface area detector will also prove advantageous for use in in vitro measurements. Preparation of a detector bearing a large number of different biological binding partners that occupies a Small area may be viewed as the preparation of a high density array of biological binding partners. 0011. The creation of high density arrays of biological binding partners where each Species of binding partner is uniquely addressed presents formidable fabrication prob lems. One of the most Successful approaches, to date, is the large Scale photolithographic Solid phase Synthesis pio neered by Affymax Inc. (see, e.g., Fodor et al. Science 251: 767-773 (1991) and U.S. Pat. No. 5, 143, 854) . In this approach arrays of peptides or nucleic acids are chemically Synthesized on a Solid Support. Different molecules are Simultaneously Synthesized at different predetermined loca tions on the Substrate by the use of a photolithographic process that Selectively removes photolabile protecting groups on the growing molecules in particular Selected locations of the Substrate. The resulting array of molecules is "spatially addressed". In other words the identity of each biological molecule is determined by its location on the Substrate. 0012. The photolithographic approach, however, is lim ited to molecules that can be chemically Synthesized. Thus, it is typically restricted to peptides shorter than about 50 amino acids and nucleic acids shorter than about 150 base pairs. In addition, the photolithographic approach typically produces Such arrays on a planar Substrate (e.g. a glass slide) and provides no intrinsic mechanism by which a signal produced by the binding of a particular biological binding partner may be transmitted. addressing the transmission ends of the first and Second fibers to the transmission array, optical interrogation means adjacent the transmission ends for examining the compara tive attachment of analytes at the Sensor ends of the fibers. The sensor ends of the first and second fibers may be arranged to form a tiered Sensor face. The first and Second binding partners may be nucleic acids, for example, DNA and cDNA, and the nucleic acids may be mapped to specific regions on one or more human chromosomes. In a particu larly preferred embodiment, the target nucleic acids are about 1,000 to 1,000,000 nucleotides in complexity. 0024 Nucleic acid bearing arrays are particularly useful in Comparative Genomic Hybridization (CGH) assays to detect chromosomal abnormalities, in particular increases or decreases in copy number of particular chromosomal regions. In one example of this approach, a first collection of (probe) nucleic acids is labeled with a first label, while a Second collection of (probe) nucleic acids is labeled with a typically refers to nucleic acids attached to the optical fibers comprising the fiber optic array, while "probe nucleic acids' are those nucleic acids free in solution that hybridize with the target nucleic acids.) The ratio of hybridization of the nucleic acids is determined by the ratio of the two (first and second) labels binding to each fiber in the array. Where there are chromosomal deletions or multiplications, differences in the ratio of the signals from the two labels will be detected. Identification of the Specific optical fibers in the array giving rise to these ratioS will indicate the nucleic acid Sequence the probe bears and thus the nucleic acid Sequence that is altered.
0025 The target nucleic acids (the nucleic acids attached to the optical fibers) may include DNA and cDNA and may be mapped to Specific regions in human chromosomes. In addition, the target nucleic acids are preferably about 1,000 to 1,000,000 nucleotides in complexity. Finally, because of the Small croSS-Sectional area of optical fibers, the bundling together into an optical array a number of optical fibers, each bearing a different biological binding partner, provides an effective mechanism for the fabrication of high density arrays of biological binding partners for suitable for a wide variety of in vivo and in vitro assays.
I. Organization of the Biosensor 0043. The unique fiber optic biosensor of the present invention, its organization, its construction and its compo nent parts are illustrated by FIGS. 1-6 respectively. Each discrete fiber optic biosensor is comprised of a plurality of fiber optic Strands 10 disposed coaxially along their lengths to form a single, discrete construction. The biosensor thus comprises an optical fiber array 14, the Smallest common repeating unit within which is a Single fiber optical Strand 10. 0044) A preferred fiber optical biosensor is illustrated by FIG. 4. As seen therein an individual fiber optical strand 10 comprises a Single optical fiber having a rodlike Shaft and two fiber ends designated a Sensor end 11 and a transmission end 12 each of which provides a Substantially planar end surface. The optical fiber strand 10 is typically composed of glass or plastic and is a flexible rod able to convey light energy introduced at either of its ends 11, 12. Such optical Sep. 26, 2002 fibers 10 are conventionally known and commercially avail able. Alternatively, the user may himself prepare optical fibers in accordance with the conventional practices and techniques reported by the Scientific and industrial literature. Accordingly, the optical fiber 10 is deemed to be conven tionally known and available as Such. 0045. It will be appreciated that FIGS. 1-6 are illustra tions in which the features have been purposely magnified and exaggerated beyond their normal Scale in order to provide both clarity and Visualization of extreme detail. Typically, the conventional optical fiber has a croSS Section diameter of 5-500 micrometers and is routinely employed in lengths ranging between centimeters (e.g. in the laboratory) to kilometers (e.g. in field telecommunications). Typically, however, when utilized in a biosensor, the optical fibers will preferably range in length from centimeters to about a meter. 0046 Although the optical fiber 10 is illustrated via FIGS. 14 as a cylindrical extended rod having substantially circular end Surfaces, there is no requirement or demand that this specific configuration be maintained. To the contrary, the optical fiber may be polygonal or asymmetrically shaped along its length, provide Special patterns and shapes at the Sensor end or transmission end and need not present an end Surface that is Substantially planar. Nevertheless, in a pre ferred embodiment, the optical fiber is substantially cylin drical.
0047. Each optical fiber 10 may be individually clad axially along its length. The cladding may be any material which has a lower refractive index and prevents the trans mission of light energy photons from the optical fiber 10 to the external environment. The cladding may thus be com posed of a variety of different chemical formulations includ ing Various glasses, Silicones, plastics, cloths, platings and Shielding matter of diverse chemical composition and for mulation. Methods of cladding including deposition, eXtru Sion, painting and covering are Scientifically and industrially available and any of these known processes may be chosen to meet the requirements and convenience of the user. 0048. The user has a variety of choices at his discretion regarding the configuration of the Sensor end 11 of the optical fiber 10. As indicated above, the sensor end 11 may present a Surface that is Substantially planar and Smooth. Alternatively the Sensor end 11 may provide an end Surface which is essentially conveX or concave. 0049. It will be appreciated that the range and variety of dimensional and configurational variation of the optical fiber 10 is limited only by the user's ability to Subsequently dispose and immobilize a biological binding partner on the intended sensor end 11 of the strand. The use of concave or convex Sensor ends 11 will provide greater Surface area upon which to immobilize a biological binding partner thereby increasing efficiency (the Signal to noise ratio per optical fiber) of the biosensor. 0050 While the single repeating component of the fiber optic biosensor is the individual optical fiber 10, it is the aggregation of a plurality of Such fibers to form a discrete optical fiber array 14 that permits the Simultaneous detection of a multiplicity of analytes. When the optical fibers are aggregated to form a discrete optical fiber array 14, the coaligned Sensor ends 11 of the fibers are aggregated to form a Sensor face 13. A typical biosensor is illustrated in 0051. In practice, it is estimated that there are typically 1000-3000 fiber optical strands in a conventional imaging fiber of 0.5 mm diameter and nearly 1 million strands per square millimeter. The total number of individual fiber optic Strands forming the optical fiber array 14 of the present invention will be approximately as great; the total number varying with the cross-sectional diameter of each optical fiber, the pattern of packing of the individual optical fibers in the collective body, and the thickness of cladding mate rial, when employed. It will be appreciated that a 1 Square millimeter biosensor, containing nearly 1 million Strands in which groups of about 33 optical fibers are each labeled with a different Species of biological binding partner will produce a sensor face 13 comprising approximately 30,000 different Species of biological binding partner in 1 Square millimeter. AS explained above, Such a Sensor could provide nucleic acid biological binding partners covering the entire human genome at 10 megabase intervals. 0.052 The sensor face 13 need not be arranged as a planar surface. Rather, the individual optical fibers may be "tiered" So as to protrude from the optical array varying distances. This will maximize the exposure of each optical fiber Sensor end 11 both to the Sample fluid and to a transilluminating light source 19 as shown in FIGS. 6A and 6B. 0053. In a preferred embodiment, the sensor ends 11 of the optical fibers comprising the optical fiber array 14 will be bundled together in a random or haphazard pattern to form the sensor face 13. Alternatively, the placement of the sensor ends 11 may be highly ordered with the sensor end of each fiber occupying a specific predetermined location in the sensor face 13. AS indicated above, the sensor ends 11 of the optical fibers 10 forming the sensor face 13 or the optical fiber array 14 have attached a biological binding partner. 0.054 Each optical fiber or group of fibers comprising the optical fiber array 14 may bear a different species of bio logical binding molecule. Although the use of a Single Species of biological binding partner per optical fiber or group of fiberS is preferred, alternatively, each optical fiber or group of fibers may bear a multiplicity of biological binding partners as long as that multiplicity differs from the biological binding partners or multiplicity of biological binding partners present on other fibers or groups of fibers comprising the optical fiber array 14. The fibers bearing like Species of binding partner may be physically grouped together thereby producing distinct regions of the Sensor face 13 characterized by the presence of a particular bio logical binding partner or alternatively the fibers bearing different binding partners may be intermingled, the Sensor face 13 presenting a relatively uniform or haphazard or random distribution of Species of biological binding part CS. 0.055 The transmission face 15 of the optical array may present a Substantially planar optical array lacking any further attachments. However, in a preferred embodiment, the transmission face 15 will be permanently or removeably 0056. In addition to detecting optical signals from a fiber optic array, the detector 20, may be generally used to amplify and detect optical signals from any array of light Sources. Thus, for example, the array of light Sources may be an array of fluorescent spots as due to hybridization of fluorescently labeled probes hybridized to arrays of target nucleic acids. Similarly, the array may be of fluorescently labeled antibodies bound to an array of proteins to which the antibodies bind, or conversely fluorescently labeled proteins bound to an array of antibodies. 0057. In a preferred embodiment suitable for such appli cations, illustrated in FIGS. 7A and 7B, the detector 20 may comprise a compound objective lens 31 that consists of an array of Single lenses 32. The Single lenses are spaced So that each lens is focused on a location 34 in the array where fluorescence is to be measured. The detector may optionally include a beam splitter 35 a second lens 36 an optical filter 37 and a detection device Such as a camera 38. The beam splitter is then used to direct an excitation illumination 39 upon the array of light Sources. The resulting fluorescence at each spot is then focused through the compound objective lens 31 optionally focused by a Second lens, optionally filtered by an optical filter and then detected either visually or by a detection means Such as a camera. 0058. The compound objective may be cast, pressed, etched, or ground out of glass, plastic, quartz, or other materials well known as Suitable for lens manufacture. The compound lens may be formed as a Single piece, or alter natively may be assembled by attaching together simple lenses to form a compound objective.
II. Fabrication of the Biosensor 0059 FIGS. 1-4 illustrate a method of fabrication of a biosensor comprising a plurality of optical fibers bearing biological binding partners. In general the method involves providing a plurality of optical fibers with each fiber having a Sensor end and a transmission end with a particular Species of biological binding partner attached to the Sensor end of each fiber. Fibers with differing binding partners are com bined to form an optical fiber array wherein said fibers have commonly aligned Sensor ends for Simultaneous assay of a Sample. The transmission ends of the combined discrete fibers are addressed for interrogation to produce the fiber optic Sensor. Sep. 26, 2002 Sep. 26, 15:2891 Sep. 26, -2910 Sep. 26, (1987 which are incorporated herein by reference). Modified nucleotides can be placed on the target using PCR primers containing the modified nucleotide, or by enzymatic end labeling with modified nucleotides. 0067 Referring to FIG. 3 , after the biological binding partners 18 are attached to the sensor faces 11 of the optical fibers 10 comprising each bundle, individual fibers, or groups of fibers, are separated from each bundle. In FIG. 3 , only four fiber bundles F-F are illustrated. In the process of being Separated from each of the respective fiber bundles F-F are individual fibers 10-10. These respective fibers are being regrouped into optical fiber array 14. 0068 The individual fibers or groups of fibers, may be marked prior to Separation from the original bundle to facilitate identification of the binding partner bound to a particular fiber or group during later assembly Steps. The Separated fibers, or groups of fibers, are recombined with fibers or groups of fibers, separated from different bundles to form an optical fiber array 14 comprising a plurality of fibers or groups of fibers where each fiber or group of fibers bears a different species of biological binding partner. 0069 FIG. 4 illustrates that members of the optical fiber array 14 are oriented such that the sensor ends 11 of all of the constituent optical fiberS 10 are commonly aligned at the same end of the optical fiber array 14 thereby forming a Sensor face 13. The fibers may be arranged in a Substantially planar configuration or tiered, as illustrated in FIGS. 6A and 6B. 0070 The fibers may be bundled at the sensor face 13 in a Substantially random or haphazard manner with the rela tive location of a the sensor end 11 of a particular fiber within the sensor face 13 being determined by chance. Alternatively, the fibers may be positioned within the fiber array in a highly ordered manner Such that the location of any particular optical fiber 10 in the sensor face 13 is predetermined. 0071. The transmission ends 12 of the optical fibers comprising the optical fiber array 14 are addressed to permit interrogation and detection of binding events to the biologi cal binding partners attached to the Sensor face 13. Address ing is accomplished by any of a number of means well known to those of skill in the art. In a preferred embodiment, the transmission ends 12 of individual optical fibers, or groups of optical fiberS all bearing the same Species of biological binding partner, are Spatially addressed. This comprises localizing the optical fibers or bundles of optical fibers at fixed locations relative to the other optical fibers or bundles of optical fibers comprising the optical fiber array 14, see e.g . FIG. 4 . Most typically this may be accomplished by attaching the fiber array to a fiber optic connector and ferrule (e.g. see AMP, Inc. Harrisburg, Pa.). 0072 Alternatively, the transmission ends 12, may be addressed by attaching the transmission end of each optical fiber 10 or bundle of optical fibers bearing a particular biological binding partner to an individual detector. Each detector is Subsequently known to be associated with a particular biological binding partner and there is no need to preserve a fixed spatial relationship between any of the transmission ends 12. 0075. The detector system may be employed with a computerized data acquisition System and analytical pro gram. In this embodiment, providing a fully automated, computer controlled processing apparatus and measurement System, the data obtained from the biosensor is processed into immediately useful information. By using Such fully automated, computerized apparatus and analytical Systems, not only are a variety of different measurements made and diverse parameters measured concurrently within a single fluid Sample, but also many different fluid Samples may be analyzed individually Seriatim for detection of multiple analytes of interest concurrently-each individual fluid Sample following its predecessor in Series.
II. Methods of Use 0.076 A variety of in vitro measurements and analytical determinations may be made using a fiber optic biosensor prepared in accordance with the present invention. In vitro applications and assay techniques may be performed con currently using one or multiple fluid Samples. Each concur rently conducted measurement or determination for different analytes of interest is made individually, accurately and precisely. The observed results are then correlated and/or computed to provide precise information regarding a variety of different parameters or ligands individually. 0077. The fiber optic biosensor of the present invention may also be employed in a variety of different in vivo conditions with both humans and animals. The present invention provides accurate and precise measurements and determinations using a Single discrete fiber optic biosensor rather than the conventional bundle of different sensors joined together for limited purposes. The present invention thus provides a minimum-sized diameter Sensor for in vivo catheterization: a minimum intrusion into the bloodstream or tissueS of the living Subject for assay purposes, and a minimum of discomfort and pain to the living Subject coupled with a maximum of accuracy and precision as well Sep. 26, 2002 as a multiplicity of parameter measurement in both quali tative and/or quantitative terms. 0078. The biosensor of the present invention may be utilized for the detection of a wide variety of analytes, depending on the particular biological binding partner Selected. AS indicated above, biological binding partners are molecules that Specifically recognize and bind other mol ecules thereby forming a binding complex. Typical binding complexes include, but are not limited to, antibody-antigen, lectin-carbohydrate, nucleic acid-nucleic acid, biotin-avidin, receptor-receptor ligand, etc. Either member of the binding complex may be used as the biological binding member attached to the Sensor end 11 of the optical fibers comprising the biosensor. Thus, for example, where it is desired to detect an antibody in a Sample, the corresponding antigen may be attached to the Sensor end. Conversely, where it is desired to detect the antigen in the Sample, the antibody may be attached to the Sensor end.
0079 The selection of binding partners for a particular assay is well known to those of Skill in the art. Typically, where proteins are to be detected, antibodies are most preferred as the biological binding partner. Where enzymatic Substrates are to be detected, enzymes are preferred biologi cal binding partners, and where nucleic acids are to be detected, nucleic acid binding partners are most preferred. Thus, for example, fiber optic biosensors have been described that utilize enzymes Such as Xanthine oxidase and peroxidase to detect hypoxanthine and Xanthine (Hlavay et al., Biosensors and Bioelectronics, 9(3): 189-195 (1994) , that E. 1648: 3943 (1992) . 0080 Of course the biosensor may be designed to simul taneously detect Several different classes of analyte. Thus the Sensor may bear a combination of two or more different classes of biological binding partner. The Sensor face 13 will bear one or more binding partners Selected, for example, from the group consisting of nucleic acids, proteins, anti bodies, carbohydrates, biotin, avidin, and lectins. 0081. In the simplest application, the biosensor of the present invention may be utilized to detect a single analyte in a test Sample. The test Sample may be in Vivo, in culture, or in vitro. The assay may register simple presence or absence of the analyte or may quantify the amount of analyte present in the Sample. 0082 The assay may be run in either a direct or a competitive format. In a direct format, the amount of analyte is determined directly measuring the analyte bound to the biological binding partner. In a competitive format, a known analyte is present in the Sample and the test analyte is detected by its ability to compete the known analyte from the biological binding partners present on the Sensor face 13. 0083) In a preferred method of use, the optical fibers 10 comprising the optical fiber array 14 conduct an optical Signal indicative of the binding between a biological binding partner on the Sensor face 11 and the analyte in the Sample. The optical Signal may be produced by a number of means known to those of skill in the art. Typically the optical Signal is generated by a fluorescent, luminescent, or calorimetric label present at the sensor end 11 of the optical fiber 10. Typically the concentration of label at the sensor end of the optical fiber is a function of the concentration of analyte that Specifically binds to the biological binding partner present on that Sensor end.
0084 Methods of providing a label whose concentration is a function of the amount of an analyte Specifically asSociated with a biological binding partner are well known to those of skill in the art. In the Simplest approach, the analyte itself is labeled. Binding of the analyte to the binding partner then brings the label into proximity with the Sensor end 11 to which the binding partner is attached. Alterna tively, a labeled "blocking" analyte may be provided in the test Sample or pre-bound to the biosensor. Displacement of the labeled "blocking" analyte by the unlabeled test analyte in the Sample produces a reduction of label bound to the Sensor end where the reduction is proportional to the con centration of unlabeled analyte in the test Sample. 0085. Other approaches may use a second biological binding partner that itself is labeled. The first biological binding partner attached to the Sensor end binds and thereby immobilizes the analyte. The Second, labelled binding part ner then binds to the analyte immobilized on the sensor end thereby bringing the label in close proximity to the Sensor end where it may be detected. 0.086 Luminescent labels are detected by measuring the light produced by the label and conducted along the optical fiber. Luminescent labels typically require no external illu mination.
0087. In contrast colorimetric or fluorescent labels typi cally require a light Source. Colorimetric labels typically produce an increase in optical absorbance and/or a change in the absorption spectrum of the solution. Colorimetric labels are measured by comparing the change in absorption Spec trum or total absorbance of light produced by a fixed light Source. In the present invention, the change in light absor bance or absorption Spectrum is preferably detected through the optical fibers comprising the biosensor. The change in absorbance, or absorption Spectrum, may be measured as a change in illumination from an absolutely calibrated light Source, or alteratively may be made relative to a Second "reference light Source'. The light Source may be external to the biosensor or may be provided as an integral component. In one embodiment, Some of the constituent optical fibers will conduct light from the Signal and/or reference Source to the Sensor face. For maximum Sensitivity the light used to measure absorbance, or absorption spectrum, changes will be directed directly at the sensor face of the biosensor. incorporated herein by reference). 0090. In another embodiment, the excitation illumination is provided external to the biosensor. It is particularly preferred that the illumination be provided as a "transillu mination" normal to the sensor ends 11 of the optical fibers (see, e.g . FIG. 4) . This provides an increased signal to noise ratio as, in this configuration, most of the excitation illumi nation will not be conducted along the optical fibers. The individual optical fibers 10 comprising the biosensor may be tiered, for example, as shown in FIGS. 6A and 6B, to prevent individual fibers from shadowing each other when transilluminated.
0091 To optimize a given assay format one of skill can determine sensitivity of fluorescence detection for different combinations of optical fiber, Sensor face configuration, fluorochrome, excitation and emission bands and the like.
The sensitivity for detection of analyte by various optical fiber array configurations can be readily determined by, for example, using the biosensor to measure a dilution Series of fluorescently labeled analytes. The Sensitivity, linearity, and dynamic range achievable from the various combinations of are labelled with different labels and then hybridized in situ to metaphase chromosomes of a reference cell. The repeti tive sequences in both the reference and test DNAS may be removed or their hybridization capacity may be reduced by Some means Such as an unlabeled blocking nucleic acid (e.g. Cot-1). Chromosomal regions in the test cells which are at increased or decreased copy number can be quickly identi fied by detecting regions where the ratio of Signal from the two DNAS is altered. For example, those regions that have been decreased in copy number in the test cells will show relatively lower signal from the test DNA than the reference compared to other regions of the genome. Regions that have been increased in copy number in the test cells will show relatively higher signal from the test DNA. 0094. In one embodiment, the present invention provides a CGH assay in which the biosensor of the present invention replaces the metaphase chromosome used as the hybridiza tion target in traditional CGH. Instead, the biological bind ing partners present on the biosensor are nucleic acid Sequences Selected from different regions of the genome. The biosensor itself becomes a sort of "glass chromosome" where hybridization of a nucleic acid to a particular binding partner is informationally equivalent to hybridization of that nucleic acid to the region on a metaphase chromosome from which the biological binding partner is derived. In addition, nucleic acid binding partners not normally contained in the genome, for example virus nucleic acids, can be employed. 0.095 More particularly, in a CGH assay, the biosensor may be utilized in methods for quantitatively comparing copy numbers of at least two nucleic acid Sequences in a first collection of nucleic acid molecules relative to the copy numbers of those same Sequences in a Second collection, as illustrated in FIG. 5. The method comprises labeling the nucleic acid molecules in the first collection 25 and the nucleic acid molecules in the Second collection 26 with first and Second labels, respectively thereby forming at least two collections of nucleic acid probes. The first and Second labels should be distinguishable from each other. 0.096 AS used herein, the term "probe' is thus defmed as a collection of nucleic acid molecules (either RNA or DNA) capable of binding to a target nucleic acid of complementary Sequence through one or more types of chemical bonds, usually through hydrogen bond formation. The probes are preferably directly or indirectly labelled as described below. They are typically of high complexity, for instance, being prepared from total genomic DNA or MRNA isolated from a cell or cell population. 0097. The probes 30 thus formed are contacted, either Simultaneously or Serially, to a plurality of target nucleic acids, present on the Sensor face 13 of the biosensor of array 14 under conditions Such that nucleic acid hybridization to the target nucleic acids can occur. Here a tranilluminating light source 19 is utilized. After contacting the probes to the target nucleic acids the amount of binding of each probe, and ratio of the binding of the probes is determined for each Species of target nucleic acid. Typically the greater the ratio of the binding to a target nucleic acid, the greater the copy number ratio of Sequences in the two probes that bind to nucleic acid. Thus comparison of the ratioS of bound labels among target nucleic acid Sequences permits comparison of copy number ratios of different Sequences in the probes. 0098. In a preferred embodiment, the sequence complex ity of each target nucleic acid in the biosensor is much leSS than the Sequence complexity of the first and Second col lections of labeled nucleic acids. The term "complexity" is used here according to Standard meaning of this term as established by Britten et al. Methods of Enzymol. 29:363 (1974) . See, also Cantor and Schimmel Biophysical Chem istry. Part III at 1228-1230 for further explanation of nucleic acid complexity. 0099. The methods are typically carried out using tech niques Suitable for fluorescence in Situ hybridization. Thus, the first and Second labels are usually fluorescent labels. 0100. To inhibit hybridization of repetitive sequences in the probes to the target nucleic acids, unlabeled blocking nucleic acids (e.g., Cot-1 DNA) can be mixed with the probes. Thus, the invention focuses on the analysis of the Sep. 26, 2002 non-repetitive Sequences in a genome. However, use of repetitive Sequences as targets on the biosensor and omiting the blocking nucleic acids would permit relative copy num ber determinations to be made for repetitive Sequences. 0101. In a typical embodiment, one collection of probe nucleic acids is prepared from a test cell, cell population, or tissue under Study; and the Second collection of probe nucleic acids is prepared from a reference cell, cell popu lation, or tissue. Reference cells can be normal non-diseased cells, or they can be from a Sample of diseased tissue that Serves as a Standard for other aspects of the disease. For example, if the reference probe is genomic DNA isolated from normal cells, then the copy number of each Sequence in that probe relative to the others is known (e.g., two copies of each autosomal Sequence, and one or two copies of each SeX chromosomal sequence depending on gender). Compari
Son of this to a test probe permits detection in variations from normal. Alternatively the reference probe may be prepared from genomic DNA from a primary tumor which may contain Substantial variations in copy number among its different Sequences, and the test probe may prepared from genomic DNA of metastatic cells from that tumor, so that the comparison shows the differences between the primary tumor and its metastasis. Further, both probes may be prepared from normal cells. For example comparison of mRNA populations between normal cells of different tissues permits detection of differential gene expression that is a critical feature of tissue differentiation. Thus in general the terms test and reference are used for convenience to distin guish the two probes, but they do not imply other charac teristics of the nucleic acids they contain.
Target Nucleic Acids 0102) The target nucleic acids comprising the biological binding partners attached to the Sensor ends 11 of the optical fibers 10 and the probes may be, for example, RNA, DNA, or cDNA. The nucleic acids may be derived from any organism. Usually the nucleic acid in the target Sequences and the probes are from the same species. 0103) The "target nucleic acids" comprising biological binding partners typically have their origin in a defimed region of the genome (for example a clone or several contiguous clones from a genomic library), or correspond to a functional genetic unit, which may or may not be complete (for example a full or partial clDNA). The target nucleic acids can also comprise inter-Alu or Degenerate Oligonucle otide Primer PCR products derived from such clones. If gene expression is being analyzed, a target element can comprise a full or partial cDNA. 0104. The target nucleic acids may, for example, contain Specific genes or, be from a chromosomal region Suspected of being present at increased or decreased copy number in cells of interest, e.g., tumor cells. The target nucleic acid may also be an mRNA, or cDNA derived from such mRNA, Suspected of being transcribed at abnormal levels. 0105. Alternatively, target nucleic acids may comprise nucleic acids of unknown significance or location. The array of Such target nucleic acids comprising the Sensor face 13 of a biosensor of the present invention could represent nucleic acids derived from locations that Sample, either continu ously or at discrete points, any desired portion of a genome, including, but not limited to, an entire genome, a Single chromosome, or a portion of a chromosome. The number of target elements and the complexity of the nucleic acids in each would determine the density of Sampling. For example an biosensor bearing 300 different species of target nucleic acid (biological binding partners), each target nucleic acid being DNA from a different genomic clone, could Sample the entire human genome at 10 megabase intervals. An array of 30,000 elements, each containing 100 kb of genomic DNA could give complete coverage of the human genome. 0106 Similarly, an array of target nucleic acids compris ing nucleic acids from anonymous cDNA clones would permit identification of those that might be differentially expressed in Some cells of interest, thereby focusing atten tion on Study of these genes. 0107. In some embodiments, previously mapped clones from a particular chromosomal region of interest are used as targets. Such clones are becoming available as a result of rapid progress of the Worldwide initiative in genomics. Probes and Libraries, 7th ed. 1993). 0110) If necessary, clones described above may be geneti cally or physically mapped. For instance, FISH and digital image analysis can be used to identify and map the locations on a chromosome to which specific coSmid inserts hybrid ize. This method is described, for instance, in Lichter et al., Science, 247:64-69 (1990) . The physically mapped clones can then be used to more finally map a region of interest identified using CGH or other methods. 0111 One of skill will recognize that each target nucleic acids may be Selected So that a number of nucleic acids of different length and Sequence represent a particular region on a chromosome. Thus, for example, a the Sensor face 13 of the biosensor may bear more than one copy of a cloned piece of DNA, and each copy may be broken into fragments of different lengths. One of skill can adjust the length and complexity of the target Sequences to provide optimum hybridization and Signal production for a given hybridiza tion procedure, and to provide the required resolution among different genes or genomic locations. Typically, the target Sequences will have a complexity between about 1 kb and about 1 Mb.
Preparation of Probe Nucleic Acids 0112 As with target nucleic acids (those attached to the fiber optic Sensor), a wide variety of nucleic acids can be used as probe nucleic acids in the methods of the present invention. The probes may be comprise, for example, genomic DNA representing the entire genome from a par Sep. 26, 2002 ticular organism, tissue or cell type or may comprise a portion of the genome, Such as a single chromosome. 0113 To compare expression levels of a particular gene or genes, the probe nucleic acids can be derived from mRNA or cDNA prepared from an organism, tissue, or cell of interest. For instance, test cDNA or MRNA, along with MRNA or cDNA from normal reference cells, can be hybridized to an array of target nucleic acids on the Sensor comprising clones from a normalized cDNA library. In addition, probes made from genomic DNA from two cell populations can be hybridized to a target cDNA array to detect those cDNAs that come from regions of variant DNA copy number in the genome. 0114. The methods of the invention are suitable for comparing copy number of particular Sequences in any combination of two or more populations of nucleic acids. One of skill will recognize that the particular populations of Sample nucleic acids being compared is not critical to the invention. For instance, genomic or cDNA can be compared from two related Species. Alternatively, levels of expression of particular genes in two or more tissue or cell types can be compared. AS noted above, the methods are particularly useful in the diagnosis of disease. 0115 Standard procedures can be used to isolate nucleic acids (either DNA or MRNA) from appropriate tissues (see, 0116. The particular cells or tissue from which the nucleic acids are isolated will depend upon the particular application. Typically, for detection of abnormalities asso ciated with cancer, genomic DNA is isolated from tumor cells. For prenatal detection of disease, fetal tissue will be used. 0.117) If the tissue sample is small, so that a small amount of nucleic acids is available, amplification techniqueS Such as the polymerase chain reaction (PCR) using degenerate primers can be used. For a general description of PCR, See, PCR Protocols, Innis et al. eds. Academic Press, 1990 . In addition, PCR can be used to Selectively amplify Sequences between high copy repetitive Sequences. These methods use primers complementary to highly repetitive interspersed Sequences (e.g., Alu) to selectively amplify sequences that are between two members of the Alu family (see, Nelson et al., Proc. Nati. Acad. Sci. USA 86:6686 (1989) ). 0118 CGH, at the cytogenetic level, facilitates the search for disease genes by identifying regions of differences in copy number between a normal and tumor genome, for example. For instance, CGH Studies have been applied to the analysis of copy number variation in breast cancer (see, e.g., Kallioniemi et al. Proc. Natl. Acad. Sci. USA 91:2156 -2160 (1994)). 0119). In CGH, the resolution with which a copy number change can be mapped is on the order of Several megabases. With the present invention the resolution is a function of the length of the genomic DNA segments comprising the target nucleic acid Sequences and the difference in map position between neighboring clones. Resolution of more than a factor of 10 better than with standard CGH can be achieved with the present invention. This improved localization will facilitate efforts to identify the critical genes involved in a disease, and permit more Sensitive detection of abnormali ties involving a Small region of the genome, Such as in microdeletion Syndromes.
Labeling Nucleic Acid Probes 0120 AS noted above, the nucleic acids which are hybridized to the target nucleic acids are preferably labeled to allow detection of hybridization complexes. The nucleic acid probes used in the hybridization described below may be detectably labeled prior to the hybridization reaction. Alternatively, a detectable label may be selected which binds to the hybridization product. AS noted above, the target nucleic acid array is hybridized to two or more probe nucleic acids, either simultaneously or Serially. Thus, the probes are each preferably labeled with a separate and distinguishable label.
0121
The particular label or detectable group attached to the probe nucleic acids is Selected So as to not significantly interfere with the hybridization of the probe to the target Sequence. The detectable group can be any material having a detectable physical or chemical property. Such detectable labels have been well-developed in the field of nucleic acid hybridizations and in general most any label useful in Such methods can be applied to the present invention. Thus a label is any composition detectable by Spectroscopic, photo chemical, biochemical, immunochemical, electrical, optical or chemical means.
0122. However, preferred labels produce an optical sig nal. Thus, particularly useful labels in the present invention include fluorescent dyes (e.g., fluorescein isothiocyanate, texas red, rhodamine, and the like) and labels that produce a colorimetric Signal Such as various enzymes (e.g., horse radish peroxidase, alkaline phosphatase and others com monly used in an ELISA). 0123 The nucleic acids can be indirectly labeled using ligands for which detectable anti-ligands are available. For example, biotinylated nucleic acids can be detected using labeled avidin or Streptavidin according to techniques well known in the art. In addition, antigenic or haptenic mol ecules can be detected using labeled antisera or monoclonal antibodies. For example, N-acetoxy-N-2-acetylaminofluo rene-labelled or digoxigenin-labelled probes can be detected using antibodies Specifically immunoreactive with these compounds (e.g., FITC-labeled sheep anti-digoxigenin anti body (Boehringer Mannheim)). In addition, labeled antibod ies to thymidine-thymidine dimers can be used (Nakane et al. ACTA Histochem. Cytochem. 20:229 (1987) ). 0.124 Generally, labels which are detectable in as low a copy number as possible, thereby maximizing the Sensitivity of the assay, and yet be detectable above any background Signal are preferred. A label is preferably chosen that pro vides a localized signal, thereby providing Spatial resolution of the Signal from each target element. 0.125 The labels may be coupled to the DNA in a variety of means known to those of skill in the art. In a preferred embodiment the probe will be labeled using nick transla tiotor random primer extension (Rigby, et al. J. Mol. Biol., 113: 237 (1977 ) or Sambrook, et al., Molecular Cloning A Laboratory Manual, Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y. (1985 ). Sep. 26, 2002 Hybridization of Labeled Nucleic Acids to Targets 0.126 The copy number of particular nucleic acid Sequences in two probes are compared by hybridizing the probes to one or more target nucleic acid arrays (biosensors).
The hybridization signal intensity, and the ratio of intensi ties, produced by the probes on each of the target elements is determined. Typically the greater the ratio of the Signal intensities on a target nucleic acid the greater the copy number ratio of Sequences in the two probes that bind to that target Sequence. Thus comparison of the Signal intensity ratioS among target elements permits comparison of copy number ratioS of different Sequences in the probes. 0127 Standard hybridization techniques are used to probe a target nucleic acid array. 43-65 (plenum Press, N.Y. 1985) . 0128 Generally, nucleic acid hybridizations utilizing the biosensors of the present invention comprise the following major steps: (1) prehybridization treatment to increase accessibility of target DNA, and to reduce nonspecific binding; (2) hybridization of the mixture of nucleic acids to the nucleic acid targets on the biosensor; (3) posthybridiza tion washes to remove nucleic acid fragments not bound in the hybridization and (4) detection of the hybridized nucleic acid fragments. The reagent used in each of these Steps and their conditions for use vary depending on the particular application. 0129. In some applications it is necessary to block the hybridization capacity of repetitive Sequences. A number of methods for removing and/or disabling the hybridization capacity of repetitive sequences are known (see, e.g., WO 9/18186). 0.130 For instance, bulk procedures can be used. In many genomes, including the human geome, a major portion of shared repetitive DNA is contained within a few families of highly repeated Sequences Such as Alu. These methods exploit the fact that hybridization rate of complementary Sequences increases as their concentration increases. Thus, repetitive Sequences, which are generally present at high concentration will become double Stranded more rapidly than others following denaturation and incubation under hybridization conditions. The double stranded nucleic acids are then removed and the remainder used in hybridizations. Methods of Separating Single from double Stranded Sequences include using hydroxyapatite or immobilized complementary nucleic acids attached to a Solid Support. Alternatively, the partially hybridized mixture can be used and the double stranded sequences will be unable to hybrid ize to the target. 0131 Alternatively, unlabeled sequences which are complementary to the Sequences whose hybridization capac ity is to be inhibited can be added to the hybridization mixture. This method can be used to inhibit hybridization of repetitive Sequences as well as other Sequences. For instance, "Cot-1 DNA can be used to selectively inhibit hybridization of repetitive Sequences in a Sample. To prepare Cot-1 DNA, DNA is extracted, sheared, denatured and renatured to a Cot-1 (for description of reasSociation kinetics and Cot values, See, Tijssen, Supra at pp. 48-54). Because highly repetitive Sequences reanneal more quickly, the resulting hybrids are highly enriched for these Sequences.
The remaining single Stranded (i.e., single copy sequences)
is digested with S1 nuclease and the double stranded Cot-1 DNA is purified and used to block hybridization of repetitive Sequences in a Sample. Although Cot-1 DNA can be pre pared as described above, it is also commercially available (BRL). Reassociation to large Cot values will result in blocking DNA containing reptitive Sequences that are present at lower copy number.
Analysis of Detectable Signals from Hybridizations 0132) Standard methods for detection and analysis of Signals generated by labeled probes can be used. In particu lar, the optical Signal produced by binding of a labeled probe to a particular binding partner will be carried along the optical fibers 10, to which that binding partner is attached. AS indicated above, the optical Signal may be visualized directly or transduced into an analog or digital electronic signal by means of a detector 20. To facilitate the display of results and to.improve the Sensitivity of detecting Small differences in fluorescence intensity, a detector and a digital Signal analysis System is preferably used. The detector may be equipped with one or more filters to pass the emission wavelengths while filtering out excitation wavelengths thereby increasign the Signal to noise ratio. The use of filters will also facilitate distinguishing between binding events involving the two, or more, differently labeled probes. Such detector/filter/signal processing Systems are well known to those of skill in the art.
What is claimed is: 1. A proceSS for constructing a fiber optic bundle for Sensing a plurality of biological binding partners within a Sample, the proceSS comprising the Steps of: providing a plurality of optical fibers with each fiber having a Sensor end and a transmission end wherein each fiber has attached to its Sensor end a Species of biological binding partner; combining Said fibers with differing binding partners to form an optical fiber array wherein said fibers have commonly aligned Sensor ends for Simultaneous assay of a Sample, and, addressing the transmission end of the combined discrete fibers for interrogation to produce the fiber optic Sensor for the Sample. 2. The process of claim 1, wherein Said providing Step comprises:
providing a plurality of optical fibers with each fiber having a Sensor end and a transmission end; placing the plurality of optical fibers in a plurality of fiber groups, each fiber group with commonly aligned Sensor the Sensor end of at least one first fiber having attached a first biological binding partner, 24. The method of claim 20, wherein the target nucleic acids are mapped to specific regions in human chromo SOCS. 25. The method of claim 20, wherein the target nucleic acids are about 1000 to about 1,000,000 nucleotides in complexity.
26. The method of claim 20, wherein the complexity of the Sequence complementary to the target nucleic acid Sequence is less than 1% of the total complexity of the Sequences in the sample. 
